Article Details
Retrieved on: 2018-01-13 05:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Bridgewater Associates</b> Lp, which manages about $14.91 billion US Long portfolio, decreased its stake in Charles Riv Labs Intl Inc (NYSE:CRL) by 4,135 shares to 2,574 shares, valued at $278,000 in 2017Q3, according to the filing. It also reduced its holding in Newfield Expl Co (NYSE:NFX) by 422,234 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here